Chula Vista, CA, United States of America

John M Frazer

This inventor holds 1 USPTO granted patent. Top assignee: Synbiotics Corporation. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John M Frazer. Retrieved from https://idiyas.com/inventor/john-m-frazer-t5zu0od3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John M Frazer: Innovator in Enzyme Immunoassay Procedures

Introduction

John M Frazer is a notable inventor based in Chula Vista, California. He has made significant contributions to the field of immunology through his innovative work. His expertise is particularly evident in the development of enzyme immunoassay procedures.

Latest Patents

John M Frazer holds a patent for an "Enzyme immunoassay procedure for amphipathic analytes." This patent describes immunoreagents for the release, non-specific capture, and detection of lipopolysaccharides (LPS). These LPS may serve as diagnostic indicators for microorganisms that cause diseases such as Chlamydia trachomatis or Chlamydia psittaci. He has 1 patent to his name.

Career Highlights

Frazer is associated with Synbiotics Corporation, where he applies his knowledge and skills in immunology. His work has contributed to advancements in diagnostic procedures, enhancing the ability to detect specific pathogens.

Collaborations

Throughout his career, John M Frazer has collaborated with notable colleagues, including William B Freese and Michael S Voegtline. These partnerships have fostered innovation and development in their respective fields.

Conclusion

John M Frazer's contributions to enzyme immunoassay procedures highlight his role as an important inventor in the field of immunology. His work continues to impact diagnostic methodologies and improve healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…